Santen Pharmaceutical Co Ltd
OTC:SNPHY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Santen Pharmaceutical Co Ltd
OTC:SNPHY
|
JP |
|
Lanthanein Resources Ltd
F:TG50
|
AU |
|
O
|
Olympus Corp
XMUN:OLY1
|
JP |
|
Concord Medical Services Holdings Ltd
NYSE:CCM
|
CN |
|
G
|
Geodrill Ltd
F:7GD
|
IM |
|
Techtronic Industries Co Ltd
F:TIB1
|
HK |
|
A
|
Arcos Dorados Holdings Inc
F:AD8
|
UY |
|
A
|
Arecor Therapeutics PLC
F:6UI
|
UK |
|
Guardion Health Sciences Inc
F:0QTA
|
US |
|
Z
|
ZincX Resources Corp
F:M9R
|
CA |
|
Y
|
Yulon Finance Corp
TWSE:9941A
|
TW |
|
B
|
Booktopia Group Ltd
F:BK4
|
AU |
Bankruptcy Probability
Santen Pharmaceutical Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Santen Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JP |
|
Santen Pharmaceutical Co Ltd
TSE:4536
|
598.1B JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.2T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
657.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
386.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
241.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
189.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
285.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Santen Pharmaceutical Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Santen Pharmaceutical Co Ltd has total debt of 31B JPY. This includes both short-term (0 JPY) and long-term (31B JPY) debt.
You can find a full breakdown on its Balance Sheet.
